GenMark Awarded BARDA Grant for the Development of ePlex® RP2 Panel
23. März 2020 19:45 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has...
GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test
19. März 2020 21:23 ET
|
GenMark Diagnostics, Inc.
COVID-19 diagnosis in under two hours now available globally in hospitals on company’s ePlex System Unique sample-to-answer capability enables near patient testing for the most critical patient...
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its ePlex® SARS-CoV-2 Test
11. März 2020 08:00 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results
02. März 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Announces Global Shipments of ePlex® RUO Test Kits Designed for SARS-CoV-2 Detection
02. März 2020 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
GenMark Diagnostics to Participate in the Cowen Health Care Conference
18. Februar 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 2, 2020
10. Februar 2020 17:30 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market...
GenMark Diagnostics Announces CEO and Chairman Transition
10. Februar 2020 17:15 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019
13. Januar 2020 07:00 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
GenMark Diagnostics to Participate in the J.P. Morgan Healthcare Conference
30. Dezember 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...